Evidence map›Paper›PMID 36518034›Full record

ArticleDrug metabolism and bioanalysis letters2023

CYP2D6 and CYP2C19 Genes Associated with Tricontinental and Latin American Ancestry of Pe-ruvians

Angel T Alvarado, María Saravia, Ricardo Losno, Ricardo Pariona, Ana María Muñoz, Roberto O Ybañez-Julca, Berta Loja, María R Bendezú, Jorge A García, Felipe Surco-Laos and 4 more

Abstract read
In one paragraph

Article in Drug metabolism and bioanalysis letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Association BetweenPharmaceuticals (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Angel T AlvaradoInternational Research Network in Pharmacology and Precision Medicine, Human Medicine School, San Ignacio de Loyola University, USIL, 15024, Lima, Peru.
María SaraviaInternational Research Network in Pharmacology and Precision Medicine, Human Medicine School, San Ignacio de Loyola University, USIL, 15024, Lima, Peru.
Ricardo LosnoInternational Research Network in Pharmacology and Precision Medicine, Human Medicine School, San Ignacio de Loyola University, USIL, 15024, Lima, Peru.
Ricardo ParionaInternational Research Network in Pharmacology and Precision Medicine, Human Medicine School, San Ignacio de Loyola University, USIL, 15024, Lima, Peru.
Ana María MuñozInstitute of Food Science and Nutrition, ICAN, San Ignacio de Loyola University, USIL, 15024, Lima, Peru.
Roberto O Ybañez-JulcaFaculty of Pharmacy and Biochemistry, National University of Trujillo, 13001, Trujillo, Peru.
Berta LojaInternational Research Network in Pharmacology and Precision Medicine, Human Medicine School, San Ignacio de Loyola University, USIL, 15024, Lima, Peru.
María R BendezúFaculty of Pharmacy and Biochemistry, San Luis Gonzaga National University of Ica, 11001, Ica, Peru.
Jorge A GarcíaFaculty of Pharmacy and Biochemistry, San Luis Gonzaga National University of Ica, 11001, Ica, Peru.
Felipe Surco-LaosFaculty of Pharmacy and Biochemistry, San Luis Gonzaga National University of Ica, 11001, Ica, Peru.
Doris Laos-AnchanteFaculty of Pharmacy and Biochemistry, San Luis Gonzaga National University of Ica, 11001, Ica, Peru.
Haydee ChávezFaculty of Pharmacy and Biochemistry, San Luis Gonzaga National University of Ica, 11001, Ica, Peru.
Priscilia AguilarHuman Medicine, Continental University,15304, Lima, Peru.
Mario PinedaPharmacy and Biochemistry, FCS, Scientific of the South University, UCSUR, 15067, Lima, Peru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precision medicine seeks to individualize the dose from the beginning of phar-macological therapy based on the characteristics of each patient, genes involved in the metabolic phenotype, ethnicity or miscegenation, with the purpose to minimize adverse effects and optimize drug efficacy. The objective was to re-view studies that describe the association of the CYP2D6 and CYP2C19 genes with the tricontinental and Latin American ancestry of Peruvians. A biblio-graphic search was carried out in PubMed/Medline and SciELO, with various descriptors in Spanish and English. The results of this review confirm that the ethnic origin of Peruvians is triconti-nental due to European (mainly Spanish), African and Asian migration, in addi-tion to Latin American migration, being 60.2% mixed, 25.8% Amerindian, 5.9% white, 3.6% African descent, 1.2% Chinese and Japanese descent, and 3.3% unspecified. Studies on CYP2C19*3, CYP2D6*2, *3 and *6 have been reported in Peruvians, and the frequency is similar to that studied in Ecuadori-ans and Colombians. The CYP2C19*3, CYP2D6*3, and CYP2D6*6 alleles found in Peruvians are common in Europeans, Africans, and Asians; while CYP2D6*4 in Africans and CYP2D6*2 related to Asians. In some studies, the ethnic/gene association has not been demonstrated; while others have shown a significant association, which is why further investigation is warranted. It is concluded that the studies on CYP2D6 and CYP2C19 genes associated with the tricontinental and Latin American ancestry of Peruvians are little, and ac-cording to what has been investigated, the CYP2C19*3, CYP2D6*2, *3, *4 and *6 alleles have more related to their ancestry.

Indexed as

CYP2C19CYP2D6EthnicityPeruvians.Pharmacogenetics

Identifiers

PMID36518034
PMCPMC10436705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.